top of page

Gender, metabolism and genetics may play a crucial role in lower cancer risk after bariatric surgery

Two studies, led by researchers from the University of Gothenburg, have provided clues to why substantial and sustained weight-loss has been linked to a reduced risk of cancer and cancer-related death, mainly in women.


“Our results suggest that there are biological differences between individuals that affect how much cancer risk is reduced after weight loss,” said Dr Kajsa Sjöholm, associate professor at the University of Gothenburg. “By understanding these differences, we will get closer to the mechanisms underlying the connection between obesity and cancer.”


Kajsa Sjöholm and Magdalena Taube
Kajsa Sjöholm and Magdalena Taube

The findings are particularly relevant in a situation where new, highly effective drugs for weight loss are rapidly changing the treatment of obesity. Knowledge of the mechanisms behind reduced cancer risk may in the long term contribute to more accurate strategies for cancer prevention.


“In the longer term, this may pave the way for a more precision medicine approach, where preventive interventions are adapted to, for example, gender, metabolic health and genetic background,” added Dr Magdalena Taube, associate professor at the University of Gothenburg.


The studies are based on the long-term Swedish Obese Subjects study (SOS Study) that investigates the effects of weight-loss surgery. More than 4,000 individuals with obesity are included, half of whom underwent bariatric surgery. The SOS study, which is unique in the world, is led and coordinated by the University of Gothenburg.


In one of the current studies, published in PLOS Medicine, all participants in the SOS study were analysed with a focus on gender differences, insulin levels and long-term cancer outcomes. The researchers found that weight-loss following surgery was linked to both lower cancer risk and cancer-related mortality in women, but not in men.


The link was particularly clear for female-specific cancers, such as breast and gynaecological cancer, and most evident in women who had high insulin levels even before the surgery. The results indicate that insulin may be a key factor in the connection between obesity, weight loss and cancer.


In a complementary study in Scientific Reports, the researchers went a step further and investigated whether genetic background can influence the reduction in breast cancer risk following weight loss induced by bariatric surgery. The study included women with obesity who were followed for up to 33 years.


Here, it was found that women who carried a common genetic variant in the FTO genetic variant - a gene previously linked to both high BMI and increased breast cancer risk – showed the strongest association between surgery and lower breast cancer risk. In these women, the risk of breast cancer was approximately 47 percent lower after bariatric surgery compared with standard obesity treatment. In women who lacked the gene variant, no clear risk reduction was seen.


The association was even stronger in women who both carried the FTO genotype and had high insulin levels at the start of the study; in this group, the risk of breast cancer was approximately 64 percent lower after bariatric surgery. The results suggest that genetic background may affect how the body responds to extensive and long-term weight loss in terms of cancer risk.


Together, the studies indicate that the reduced risk of cancer after weight loss is unlikely to be due to a single factor. Instead, the results suggest that several biological mechanisms may interact, with factors such as insulin, gender and genetic background likely playing an important role.


One of the studies, ‘Sex-specific associations between surgery-induced weight loss and cancer outcomes: A post hoc analysis of the prospective, controlled Swedish Obese Subjects study’, was published in PLOS One. To access this paper, please click here


The second study, ‘Association between FTO rs9939609 genotype and breast cancer risk after bariatric surgery in the Swedish Obese Subjects study’, was published in Scientific Reports. To access this paper, please click here


Kajsa Sjöholm and Magdalena Taube (Credit: Göteborgs universitet, Emelie Taube)

Comments


Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net

©2026 Dendrite Clinical Systems Ltd. All rights reserved.
No part of this website may be reproduced, stored in a retrieval system, transmitted in any form or by any other means without prior written permission from the Managing Editor. The views, comments and opinions expressed within are not necessarily those of Dendrite Clinical Systems or the Editorial Board. Bariatricnews.net is a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

bottom of page